Latest Articles

Publication Date
Pulmonary endometriosis successfully treated with percutaneous radiofrequency ablation: report of two cases.

Pulmonary endometriosis (PE) is an unusual cause of catamenial hemoptysis, with only a small proportion of endometriosis cases involving the thorax. Standard management often involves surgical resection combined with hormonal …

Published: April 28, 2026, midnight
ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts.

The Ablative Technique Options for Preserving fertility in Endometrioma study is a prospective, monocentric clinical study that combines a randomised controlled trial comparing cystectomy and plasma vapourisation for endometriomas measuring …

Published: April 28, 2026, midnight
Preserving Fertility in Young Women: Triple-Step Strategy for Managing Giant Endometriomas With Minimal AMH Decline-A Case Report.

Endometriomas are a frequent cause of infertility in reproductive-aged women, often requiring surgery. However, cystectomy for large endometriomas may reduce ovarian reserve, as indicated by decreased anti-Müllerian hormone (AMH) levels. …

Published: April 28, 2026, midnight
Effect of postoperative hormonal therapy on pain following endometriosis surgery: a retrospective cohort study.

Endometriosis is heterogeneous, and evidence for individualised postoperative management is limited. We assessed whether postoperative hormonal therapy exposure is associated with one-year changes in pain domains after first-time endometriosis surgery …

Published: April 24, 2026, midnight
Cell-free regenerative therapies for female infertility: The emerging role of mesenchymal stem cell secretome.

Female reproductive disorders are a leading cause of infertility, affecting millions of women worldwide and resulting in significant emotional and social challenges. Despite advances in medical science, current treatment options …

Published: April 22, 2026, midnight
High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN

Published: April 20, 2026, 8:14 a.m.
Macrophage membrane-biomimetic nanovehicles delivering amygdalin halt pyroptosis propagation and alleviate endometriosis-associated neuropathic pain.

The clinical management of endometriosis encounters a significant obstacle: existing therapies inadequately address both the inhibition of ectopic lesion proliferation and the mitigation of the neuroinflammation associated with chronic pain. …

Published: April 20, 2026, midnight
Polypoid endometriosis mimicking aggressive pelvic malignancy on MRI in a premenopausal woman: A case report.

Polypoid endometriosis is a rare benign variant of endometriosis characterized by exuberant mass-forming endometrial tissue that can closely mimic aggressive pelvic malignancy on imaging. Although it most commonly affects peri- …

Published: April 18, 2026, midnight
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer - Pharmacy Times

Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer Pharmacy Times

Published: April 17, 2026, 12:30 p.m.
Stem cell therapy-based approaches in experimental endometriosis: a systematic review.

Published: April 17, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!